NCT02928354 - A Study to Assess the Effect of Particle Size of AZD7594 on Pharmacokinetics (PK) After a Single Inhaled Dose When Administered Using the Dry Powder Inhaler in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 25, 2016

Primary Completion Date

March 21, 2017

Study Completion Date

March 21, 2017

Conditions

Asthma, Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG

Treatment A - AZD7594

Particle size Large as a single inhaled dose of 440 µg (nominal dose), administered via DPI

DRUG

Treatment B - AZD7594

Particle size Medium as a single inhaled dose of 440 µg (nominal dose), administered via DPI

DRUG

Treatment C - AZD7594

Particle size Small as a single inhaled dose of 440 µg (nominal dose), administered via DPI

Trial Locations (1)

Research Site, Berlin